Magali Schreyer

2.5k total citations
40 papers, 2.0k citations indexed

About

Magali Schreyer is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Magali Schreyer has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Magali Schreyer's work include Monoclonal and Polyclonal Antibodies Research (26 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Immunotherapy and Immune Responses (11 papers). Magali Schreyer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (26 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Immunotherapy and Immune Responses (11 papers). Magali Schreyer collaborates with scholars based in Switzerland, Belgium and United States. Magali Schreyer's co-authors include S Carrel, Franz Buchegger, F. Buchegger, Jean‐Pierre Mach, H. Robson MacDonald, J P Mach, J.-P. Mach, Angelo Vacca, Charles M. Haskell and G Miescher and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Magali Schreyer

40 papers receiving 1.9k citations

Peers

Countries citing papers authored by Magali Schreyer

Since Specialization

Citations

This map shows the geographic impact of Magali Schreyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Schreyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Schreyer more than expected).

Fields of papers citing papers by Magali Schreyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magali Schreyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Schreyer. The network helps show where Magali Schreyer may publish in the future.

Co-authorship network of co-authors of Magali Schreyer

This figure shows the co-authorship network connecting the top 25 collaborators of Magali Schreyer. A scholar is included among the top collaborators of Magali Schreyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magali Schreyer. Magali Schreyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of Human Fibroleukin, a Fibrinogen-Like Protein Secreted by T Lymphocytes 1998 ·The Journal of Immunology ·(unknown), Stéphanie Blum, (unknown), Doris Gundersen, Magali Schreyer, Scott Argraves, V von Fliedner, Robert Pytela, Curzio Rüegg	82
2	Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells 1996 ·International Journal of Cancer ·S Carrel, Magali Schreyer, G.C. Spagnoli, Jean‐Charles Cerottini, Donata Rimoldi	22
3	Expression of type a and b tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc‐AMP and IFN‐γ 1995 ·International Journal of Cancer ·S Carrel, (unknown), Suzanne Salvi, Hugo Albrecht, Magali Schreyer, Donata Rimoldi	15
4	Mouse mammary tumor virus superantigens and murine autoimmune gastritis 1994 ·Gastroenterology ·Dirk Claeys, (unknown), Emilia Saraga, Magali Schreyer, Jacques Louis, Hans Acha‐Orbea, A. L. Blum, Jean-Pierre Kraehenbühl	10
5	Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loop 1994 ·International Journal of Cancer ·Harald Lahm, Paul Amstad, Josiane Wyniger, Aysim Yilmaz, Jürgen R. Fischer, Magali Schreyer, Jean‐Claude Givel	115
6	Selective expansion of activated Vδ4⁺ cells during experimental infection of mice with Leishmania major 1994 ·European Journal of Immunology ·Jean‐Pierre Rosat, Jacques Louis, Magali Schreyer, Toshiaki Ohteki, Gary A. Waanders, H. Robson MacDonald	6
7	Expression of CALLA/CD10 on human melanoma cells 1993 ·Melanoma Research ·S Carrel, Léonidas Zografos, Magali Schreyer, Donata Rimoldi	36
8	Malignant progression of SV40-immortalised human milk epithelial cells 1993 ·British Journal of Cancer ·(unknown), (unknown), Bernard Sordat, (unknown), Harald Lahm, Ashraf Imam, Magali Schreyer, (unknown)	6
9	Sparse distribution of γ/δ T lymphocytes around human epithelial tumors predominantly infiltrated by primed/memory T cells 1990 ·Cancer Immunology Immunotherapy ·Sylvia Miescher, Magali Schreyer, C Barras, Patrizio Capasso, V von Fliedner	14
10	Production and characterization of a rat monoclonal antibody against the murine CD3 molecular complex 1989 ·Immunology Letters ·G Miescher, Magali Schreyer, H. Robson MacDonald	51
11	Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments. 1989 ·Journal of Clinical Investigation ·F. Buchegger, (unknown), Keith F. Fournier, Florence Prével, Magali Schreyer, S Carrel, J.-P. Mach	51
12	Deletion of self-reactive T cells before entry into the thymus medulla 1988 ·Nature ·Hans Hengartner, (unknown), R Schneider, Magali Schreyer, (unknown), H. Robson MacDonald, Rolf M. Zinkernagel	147
13	Cyclic amp induces differentiation in vitro of human melanoma cells 1988 ·Cancer ·Laura Giuffrè, Magali Schreyer, Jean‐Pierre Mach, S Carrel	33
14	Radioimmunotherapy of human colon carcinoma by ¹³¹I‐labelled monoclonal anti‐cea antibodies in a nude mouse model 1988 ·International Journal of Cancer ·F. Buchegger, Angelo Vacca, S Carrel, Magali Schreyer, J P Mach	61
15	Melanoma associated differentiation antigens: investigation with monoclonal antibodies. 1988 ·PubMed ·S Carrel, Magali Schreyer, Laura Giuffrè	4
16	Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes 1987 ·Molecular Immunology ·Marie Audette, Franz Buchegger, Magali Schreyer, Jean‐Pierre Mach	70
17	Histological analysis of human tumour cell colonies grown in methylcellulose cultures 1984 ·British Journal of Cancer ·Clemente Cillo, Magali Schreyer, N Odartchenko, S Carrel	4
18	Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. 1983 ·The Journal of Experimental Medicine ·F. Buchegger, Charles M. Haskell, Magali Schreyer, B Scazziga, (unknown), S Carrel, J.-P. Mach	213
19	Reactivity Spectrum of 30 Monoclonal Antimelanoma Antibodies to a Panel of 28 Melanoma and Control Cell Lines 1982 ·Hybridoma ·S Carrel, Magali Schreyer, (unknown), J.-P. Mach	27
20	Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy 1981 ·Immunology Today ·J P Mach, Franz Buchegger, M. Forni, J Ritschard, C. Berche, (unknown), Magali Schreyer, Christophe Girardet, Roberto S. Accolla, S Carrel	274

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact